1st Mar 2023 7:00 am |
RNS |
Incorporation of Inaphaea BioLabs Limited |
24th Feb 2023 4:40 pm |
RNS |
Second Price Monitoring Extn |
24th Feb 2023 4:35 pm |
RNS |
Price Monitoring Extension |
2nd Feb 2023 12:45 pm |
RNS |
Result of GM, Issue of Equity |
31st Jan 2023 7:02 am |
RNS |
Operational Update |
31st Jan 2023 7:00 am |
RNS |
Holding(s) in Company |
17th Jan 2023 4:36 pm |
RNS |
Broker Offer Results |
17th Jan 2023 9:22 am |
RNS |
Posting of Circular and Notice of General Meeting |
13th Jan 2023 7:01 am |
RNS |
Launch of Broker Offer |
13th Jan 2023 7:00 am |
RNS |
Issue of Equity & Proposed Broker Offer |
14th Dec 2022 5:01 pm |
RNS |
Holding(s) in Company |
7th Dec 2022 1:06 pm |
RNS |
Holding(s) in Company |
6th Dec 2022 4:40 pm |
RNS |
Second Price Monitoring Extn |
6th Dec 2022 4:35 pm |
RNS |
Price Monitoring Extension |
6th Dec 2022 12:00 pm |
RNS |
Shareholder Communications and Investor Webinar |
6th Dec 2022 7:00 am |
RNS |
Quarterly Operational and Strategy Update |
24th Oct 2022 7:00 am |
RNS |
Subsidiary Launched and IP License Signed |
18th Oct 2022 7:00 am |
RNS |
Issue of Share Options |
11th Oct 2022 7:00 am |
RNS |
Director Appointment |
30th Sep 2022 8:47 am |
RNS |
Holding(s) in Company |
22nd Sep 2022 7:00 am |
RNS |
Live Shareholder Q&A and industry events |
8th Sep 2022 7:00 am |
RNS |
Appointment of Interim Chief Scientific Officer |
6th Sep 2022 7:15 am |
RNS |
Proposed Appointment of Non-Executive Director |
6th Sep 2022 7:00 am |
RNS |
Issue of Share Options |
31st Aug 2022 7:00 am |
RNS |
Half-year Report |
17th Aug 2022 7:00 am |
RNS |
Shareholder Communications |
14th Jul 2022 10:46 am |
RNS |
Holding(s) in Company |
13th Jul 2022 2:15 pm |
RNS |
Successful evaluation of breast cancer programme |
7th Jul 2022 11:07 am |
RNS |
Director/PDMR Shareholding |
5th Jul 2022 11:45 am |
RNS |
Holding(s) in Company |
5th Jul 2022 7:00 am |
RNS |
Broker Option Results |
30th Jun 2022 3:00 pm |
RNS |
Result of AGM and Appointment of Joint Broker |
30th Jun 2022 10:31 am |
RNS |
Issue of Equity |
30th Jun 2022 10:30 am |
RNS |
Extends exclusivity period for TheoremRx |
17th Jun 2022 10:01 am |
RNS |
Update on VAL201 sub-license agreement |
7th Jun 2022 4:33 pm |
RNS |
Annual Report, AGM Notice & Director Resignation |
23rd Mar 2022 7:00 am |
RNS |
Update on proposed sub-license of VAL201 |
15th Mar 2022 7:00 am |
RNS |
Operational and Strategy Update |
14th Feb 2022 7:00 am |
RNS |
Evaluation agreement with University of Barcelona |
5th Jan 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |